Global Dosimetry Solutions, Inc., Launches New Corporate Identity and Web Site

Costa Mesa, Calif., July 22, 2004 - Global Dosimetry Solutions, Inc. ("GDS") a leading provider of dosimetry services (analytical determination of exposure to ionizing radiation) today unveiled its new corporate identity and web presence. The new identity is reflective of the company's approach to integrating with customers in a seamless fashion, in order to provide unparalleled service and responsiveness within the dosimetry industry. The new web presence provides enhanced content, extensive product information and an improved user experience for GDS customers, prospects, and researchers. Through its web site, GDS will continue to be a leading source for industry news and information.

"Since becoming a fully-independent company in September of 2003, GDS has enjoyed the substantial backing of American Capital Strategies, Ltd. (NASDAQ "ACAS") a $3 billion financial sponsor. This has allowed us to invest unprecedented amounts in technology and infrastructure, all of which is designed to provide our customers with the best dosimetry service in the global industry - bar none" said Thomas Logan, CEO of Global Dosimetry. "As we continue to invest in new product development, we will also invest in expanding our customer self-service capabilities on the web. The evolution of the GDS brand marks a renewed commitment to our dosimetry customers in all segments of the industry." added Logan.

Global Dosimetry Solutions, based in Irvine, California, is one of the world's largest providers of radiation dosimetry services. GDS offers a full range of services for measuring ionizing radiation primarily through film, thermoluminescent and track etch technologies. Since early 1970, the company has continually provided state-of-the-art personal radiation monitoring services to hospitals, medical and dental offices, university and national laboratories, nuclear power plants and other industries. GDS provides services to more than 500,000 people globally. Global Dosimetry Solutions is majority owned by American Capital Strategies, Ltd. (NASDAQ: ACAS), a $3.5 billion investment fund headquartered in Bethesda, Maryland. For more information, please visit: www.dosimetry.com.